FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Mature Dry Surface Biofilm Presents a Problem for Candida Auris

Multiple methods are described in the literature, but no consensus has been reached for disinfection efficacy tests against biofilms.

Sutter Health's Arden Care Center Officially Opens

With an adaptive reuse of an underutilized office building, the 70,000 square-foot facility was renovated to meet current healthcare standards.

Insight Hospital and Medical Center Falls to Data Breach

The investigation determined that an unauthorized individual accessed the network between August 22, 2025, and September 11, 2025.

The High Cost of Healthcare Violence

As workplace violence increases, healthcare facilities face mounting financial and operational disruptions- prompting legislative action.

EVS Teams Can Improve Patient Experience in Emergency Departments

A report confirmed that cleanliness of the ED was the third most impactful element on patient experience surveys.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.